You can see trends weekly, monthly, or since you started your GLP-1 journey
If you are dealing with nausea, bloating, or reflux, reducing these can help significantly
Second, this analysis focused exclusively on a subset of GLP-1 RA therapies (specifically semaglutide and tirzepatide) and did not account for other common PCOS treatments, such as metformin, combined oral contraceptives, or anti-androgen therapies
For researchers combining retatrutide with other compounds, understanding potential supplement interactions and medication combination risks is essential regardless of dosing schedule
Wellorithm GLP-1 Program Overview 2026: How the Platform Connects Patients With Licensed Clinicians and Compounded Options GLP-1 receptor agonist medications have become one of the most talked-about developments in weight management in recent years, and access to these medications through telehealth platforms has grown significantly heading into 2026
Wegovy and Ozempic, side-by-side A few caveats about the drugs follow, but keep in mind with the marketplace driving much of the thinking, and clinical experience evolving, there may be changes in store: Wegovy is FDA-approved for chronic weight loss management in adults 18 years of age or older with a BMI of 30 or BMI 27 and at least one medical condition related to obesity (e.g., diabetes, hypertension, etc.)